Searchable abstracts of presentations at key conferences in endocrinology

ea0032p938 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Pituitary apoplexy in clinically nonfunctioning pituitary adenomas: experience of a single center

Karagiannis Apostolos , Boufas Dimitrios , Tzioras Konstantinos , Seretis Andreas , Vryonidou Andromachi

Introduction: Generously supported by IPSEN)-->Clinically nonfunctioning pituitary adenomas (CNFPA) represent 25–50% of all pituitary lesions. They may be asymptomatic and discovered incidentally or they may be diagnosed due to visual impairment or symptoms of pituitary hormone insufficiency. There is little data on apoplexy frequency in the CNFPA.The aim of our study was to assess the frequency of CNFPA a...

ea0041ep890 | Pituitary - Clinical | ECE2016

High incidence of thyroid cancer among patients with acromegaly

Kaldrymidis Dimitrios , Papadakis Georgios , Tsakonas Georgios , Kaldrymidis Philippos , Flaskas Theofanis , Seretis Andreas , Pantazi Eleni , Kostoglou-Athanassiou Ifigenia , Peppa Melpomeni , Roussou Paraskevi , Diamanti-Kandarakis Evanthia

Introduction: Several studies have suggested that patients with acromegaly have an increased risk of thyroid, colorectal, breast and prostate tumors. We determined the prevalence of malignant neoplasms in patients with acromegaly in a single Greek Centre during the years 1995–2015.Methods: We evaluated cancer risk in a cohort of 110 patients (M/F 48/62, age 58.63±13.8 years, range 30–86) with acromegaly. Mean age at diagnosis of acromegaly...